Editorial Commentary: Should "heterogeneous response" be considered as new category for assessing treatment response in patients with breast cancer?
Saved in:
| Title: | Editorial Commentary: Should "heterogeneous response" be considered as new category for assessing treatment response in patients with breast cancer? |
|---|---|
| Authors: | Vaz, Sofia C.1,2 (AUTHOR) sofia.vaz@fundacaochampalimaud.pt, Groheux, David3,4,5 (AUTHOR) dgroheux@yahoo.fr, van Nijnatten, Thiemo6,7 (AUTHOR) thiemo.nijnatten@mumc.nl, Antunovic, Lidija8 (AUTHOR), Cardoso, Fatima9,10 (AUTHOR) maria.joao.cardoso@fundacaochampalimaud.pt, Mottaghy, Felix6,11,12 (AUTHOR) fmottaghy@ukaachen.de, Cardoso, Maria Joao9,13 (AUTHOR), Riedl, Christopher14 (AUTHOR), de Geus-Oei, Lioe-Fee2,15,16 (AUTHOR) l.f.de_geus-oei@lumc.nl, Ulaner, Gary A.17,18 (AUTHOR) Gary.Ulaner@hoag.org |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Feb2025, Vol. 52 Issue 3, p801-805. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16197070 |
|---|---|
| DOI: | 10.1007/s00259-024-07042-9 |
